Dolby Laboratories, Inc.
DLB
$65.27
$1.081.68%
NYSE
| 06/26/2026 | 03/27/2026 | 12/26/2025 | 09/26/2025 | 06/27/2025 | |
|---|---|---|---|---|---|
| Revenue | -3.34% | 7.05% | -2.88% | 0.73% | 9.25% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -3.34% | 7.05% | -2.88% | 0.73% | 9.25% |
| Cost of Revenue | -8.37% | 24.82% | 5.97% | 16.25% | 23.38% |
| Gross Profit | -2.53% | 5.15% | -4.02% | -1.22% | 7.26% |
| SG&A Expenses | 1.38% | 7.54% | -1.64% | 4.54% | 7.95% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -0.64% | 8.89% | 0.80% | 4.42% | 8.27% |
| Operating Income | -18.73% | 2.82% | -14.65% | -20.55% | 15.25% |
| Income Before Tax | -21.10% | -0.46% | -16.79% | -30.24% | 10.67% |
| Income Tax Expenses | 62.56% | -13.48% | -0.33% | -1,020.05% | -14.61% |
| Earnings from Continuing Operations | -37.23% | 3.50% | -21.14% | -15.65% | 17.37% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -29.94% | -24.48% | -42.74% | -8.78% | 61.11% |
| Net Income | -37.92% | 3.40% | -21.37% | -15.77% | 19.84% |
| EBIT | -18.73% | 2.82% | -14.65% | -20.55% | 15.25% |
| EBITDA | -11.81% | 4.28% | -9.95% | -12.98% | 16.65% |
| EPS Basic | -36.82% | 4.61% | -21.25% | -15.98% | 19.56% |
| Normalized Basic EPS | -12.22% | -1.32% | -10.17% | -18.45% | 3.45% |
| EPS Diluted | -37.50% | 5.32% | -21.43% | -15.03% | 20.00% |
| Normalized Diluted EPS | -11.55% | -0.45% | -9.72% | -18.47% | 3.71% |
| Average Basic Shares Outstanding | -1.73% | -1.15% | -0.16% | 0.25% | 0.22% |
| Average Diluted Shares Outstanding | -2.46% | -2.01% | -0.65% | 0.26% | -0.06% |
| Dividend Per Share | 9.09% | 9.09% | 9.09% | 9.09% | 10.00% |
| Payout Ratio | 0.73% | 0.04% | 0.38% | 0.31% | -0.08% |